ACA
BSX icon

Affinity Capital Advisors’s Boston Scientific BSX Stock Holding History

Affinity Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$487K Buy
10,920
+1,054
+11% +$57.2K 0.06% 115
2026
Q1 		$619K Buy
+9,866
New +$789K 0.09% 88

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Affinity Capital Advisors's BSX Position: Q2 2026 in Review

Affinity Capital Advisors increased its Boston Scientific (BSX) stake by 11% in Q2 2026, buying an estimated $57.2K and bringing the position to 10,920 shares worth $487K. The position accounts for 0.06% of the portfolio, ranked #115.

Affinity Capital Advisors first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $619K in Q1 2026. 179 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Affinity Capital Advisors held 10,920 shares of Boston Scientific worth $487K as of Q2 2026.
  • Affinity Capital Advisors bought 1,054 Boston Scientific shares in Q2 2026, an estimated $57.2K.
  • Boston Scientific made up 0.06% of Affinity Capital Advisors's portfolio in Q2 2026, its #115 holding.
  • Affinity Capital Advisors first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Affinity Capital Advisors's Boston Scientific position peaked at $619K in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Affinity Capital Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.